Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects

Three types of oligonucleotide-based medicines are under clinical development for the treatment of chronic HBV infection. Antisense oligonucleotides (ASOs) and synthetic interfering RNA (siRNA) are designed to degrade HBV mRNA, and nucleic acid polymers (NAPs) stop the assembly and secretion of HBV...

Descripción completa

Detalles Bibliográficos
Autor principal: Vaillant, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502277/
https://www.ncbi.nlm.nih.gov/pubmed/36146858
http://dx.doi.org/10.3390/v14092052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502277/
https://www.ncbi.nlm.nih.gov/pubmed/36146858
http://dx.doi.org/10.3390/v14092052

Ejemplares similares